Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I

Table 1 Phenotypic features

	Clinical Data
Patient	Diagnosis	Sex/Age	Age of onset	Onset mode	ALA	CK	MRI findings	Comorbidity
1	FKRP	F/44	08	PLE	Amb.	NA
2	FKRP	M/64	14	PLE	30	NA	diastolic dysfunction, myocardial fibrosis	HTN
3	FKRP	F/43	18	PLE	Amb.	4486
4	FKRP	F/20	10	PLE	Amb	NA	myocardial fibrosis
5	FKRP	M/11	3	PLE	Amb	8000	myocardial fibrosis
6	FKRP	M/58	48	PLE	Amb	NA	severe systolic dysfunction, myocardial fibrosis	HTN
7	FKRP+SGCA	F/24	12	PLE	Amb	2071
8	DYSF	M/49	30	DUE+PLE	Amb	3481
9	DYSF	M/43	17	DLE	28	7938		DM,HTN
10	DYSF	M/48	25	PLE	46	9468	diastolic dysfunction	DM,HTN
11	DYSF	M/51	03	PLE	Amb	280	diastolic dysfunction, myocardial fibrosis	DM,CAD
12	DYSF	M/47	6	PLE	43	428	diastolic dysfunction, myocardial fibrosis
13	DYSF	M/54	14	DLE	45	1911	diastolic dysfunction, myocardial fibrosis	HTN
14	DYSF	F/43	19	PLE	Amb	1234		HTN
15	DYSF	F/44	16	DLE	31	320		HTN
16	DYSF	F/33	19	PLE	Amb	3046

FKRP, Fukutin-related protein; SGCA, alpha-Sarcoglycan gene; DYSF, dysferlin gene; CK, creatine kinase; DLE, distal lower extremity; DUE, distal upper extremity; PLE, proximal lower extremity; PUE, proximal upper extremity; ALA, age lost ambulation; Amb, ambulatory;HTN, hypertension; DM, diabetes mellitus, CAD, coronary artery disease; NA, no available.

ISSN: 1532-429X